Formosa Laboratories Inc
TWSE:4746

Watchlist Manager
Formosa Laboratories Inc Logo
Formosa Laboratories Inc
TWSE:4746
Watchlist
Price: 61.5 TWD 6.96% Market Closed
Market Cap: NT$7.4B

Operating Margin

16%
Current
Improving
by 2.4%
vs 3-y average of 13.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
16%
=
Operating Income
NT$784m
/
Revenue
NT$4.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
16%
=
Operating Income
NT$784m
/
Revenue
NT$4.9B

Peer Comparison

Country Company Market Cap Operating
Margin
TW
Formosa Laboratories Inc
TWSE:4746
7.4B TWD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

Higher than 80% of companies in Taiwan
Percentile
80th
Based on 1 045 companies
80th percentile
16%
Low
-21 347.1% — 0.7%
Typical Range
0.7% — 11.5%
High
11.5% — 698%
Distribution Statistics
Taiwan
Min -21 347.1%
30th Percentile 0.7%
Median 5%
70th Percentile 11.5%
Max 698%

Formosa Laboratories Inc
Glance View

Market Cap
7.4B TWD
Industry
Pharmaceuticals

Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

Intrinsic Value
89.47 TWD
Undervaluation 31%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
16%
=
Operating Income
NT$784m
/
Revenue
NT$4.9B
What is Formosa Laboratories Inc's current Operating Margin?

The current Operating Margin for Formosa Laboratories Inc is 16%, which is above its 3-year median of 13.6%.

How has Operating Margin changed over time?

Over the last 3 years, Formosa Laboratories Inc’s Operating Margin has increased from 1.9% to 16%. During this period, it reached a low of 1.9% on Aug 30, 2022 and a high of 16% on Oct 30, 2025.

Back to Top